Resultado de búsqueda
1 de abr. de 2022 · The purpose of the “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure” (2022 HF guideline) is to provide an update and to consolidate the “2013 ACCF/AHA Guideline for the Management of Heart Failure” 1 for adults and the “2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of ...
- S4.1-2
P-1,P-2 Accordingly, the ACC and AHA collaborated with the...
- 2010 Accf/Aha Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults
2022; 2021; 2020; May 2024. May 21, 2024: Vol. 149, Issue...
- Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies
The ESC working group position statement recommends that a...
- 2011 Accf/Aha Guideline for Coronary Artery Bypass Graft Surgery
2022; 2021; 2020; May 2024. May 21, 2024: Vol. 149, Issue...
- Correction To
In the article by Heidenreich et al, “2022 AHA/ACC/HFSA...
- Richard W. Nesto
The American Heart Association (AHA) and the American...
- Post–Cardiac Arrest Care
The most promising and extensively studied biomarker is...
- S4.1-2
2 de nov. de 2022 · The “2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease” provides recommendations to guide clinicians in the diagnosis, genetic evaluation and family screening, medical therapy, endovascular and surgical treatment, and long-term surveillance of patients with aortic disease across its multiple clinical ...
27 de abr. de 2022 · Guías de práctica clínica AHA/ACC/HFSA para el manejo de la insuficiencia cardiaca. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure - Sociedad Española de Cardiología Profesionales
2 de abr. de 2022 · This slide set is adapted from the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Published online ahead of print April 1, 2022, available at: Circulation. https://www.ahajournals.org/doi/10.1161/CIR.0000000000001063. And Journal of the American College of Cardiology published online ahead of print April 1, 2022. J ...
1 de abr. de 2022 · 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Published: April 01, 2022. Guideline-directed medical therapy (GDMT) for heart failure (HF) with reduced ejection fraction (HFrEF) now includes 4 medication classes which include sodium-glucose cotransporter-2 inhibitors (SGLT2i).
The 2022 heart failure guideline provides recommendations based on contemporary evidence for the treatment of these patients. The recommendations present an evidence-based approach to managing patients with heart failure, with the intent to improve quality of care and align with patients' interests.
1 de abr. de 2022 · The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure” replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the “2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure.”
